What’s likely to move the market
A trader works on the floor of the New York Stock Exchange. Stocks @ Night is a daily newsletter delivered…
Eli Lilly appoints insider Lucas Montarce as new finance chief
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey, on March 5, 2021. Mike Segar…
Best Buy is the stock of the summer — plus 2 more encouraging reports
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
It’s been nearly a year since we took profits in Eli Lilly. We’re overdue for another trim
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a…
Jim Cramer’s top 10 things to watch in the stock market Tuesday
My top 10 things to watch Thursday, Aug. 27 1. Still zero-sum? Can tech go up with rates coming down?…
Stocks making the biggest moves premarket: PARA, CAVA, JD
Check out the companies making headlines before the bell. Paramount Global — The media conglomerate’s stock dropped nearly 5% after…
Stocks making the biggest moves midday: PANW, BA, LOW, BAC
Check out the companies making headlines in midday trading: Bank of America — The bank stock slid 2% after a…
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or…
10 things to watch in the stock market Friday including more bullishness on Eli Lilly
10 things to watch in the market Friday, August 16 1. Wall Street is lower Friday morning after a strong…
All the market-moving Wall Street chatter from Wednesday
(This is CNBC Pro’s live coverage of Wednesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to…
After a busy week of trades, we’re looking to some key inflation data
It was another volatile week for stocks, but Wall Street ultimately finished lower again. The market experienced a sharp sell-off…
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, August 9 1. Is the comeback for real? The market was headed for…
Stock market today: Live updates
Stock market futures dipped on Wednesday evening as Wall Street sought to stabilize following several dramatic swings in recent days.…
Eli Lilly Zepbound, Mounjaro available after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.…
Novo Nordisk, Eli Lilly shares slide on Roche’s obesity drug trial
Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug…
Jim Cramer on Hims & Hers Health stock
CNBC’s Jim Cramer on Wednesday gave his take on Hims & Hers Health, a digital platform that offers telehealth services,…
Investors may get second half evidence of AI assistance in drug discovery
As investors peer into the future to envision which industries are ripe to be reshaped and energized by artificial intelligence,…
More U.S. employers covering GLP-1s for weight loss
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. The injectable…
Fed meeting and CPI report: Jim Cramer’s week ahead
CNBC’s Jim Cramer on Friday guided investors through next week’s most market-moving events, highlighting the Federal Reserve’s meeting and the…
Alphabet CFO Anat Ashkenazi jumps from GLP-1 boom to generative AI
Alphabet incoming CFO Anat Ashkenazi, who spent 23 years at Eli Lilly Eli Lilly Alphabet’s outgoing finance chief, Ruth Porat,…
Digital health companies are launching programs around GLP-1s
Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and…
Eli Lilly invests to increase Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.…
Eli Lilly falls on a rival’s obesity study — plus, we’re removing 3 stocks from our watchlist
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
Google’s Demis Hassabis tasked with turning AI research into profits
Demis Hassabis is a celebrated name in artificial intelligence research. He’s a chess master and a neuroscientist. On Wall Street,…
Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott…
Interest rates, AI rally stay top of mind for investors next week
As investors say farewell to a week marked by a Federal Reserve meeting, surprise labor market data and the latest…
Amgen scraps experimental weight loss pill, moves forward with injection
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty…
Fed meeting and Apple, Amazon, Eli Lilly report
CNBC’s Jim Cramer on Friday walked investors through next week on Wall Street. It’s a week jam-packed with notable events,…
stocks that declined Tuesday ‘have everything going for them’
CNBC’s Jim Cramer reviewed Tuesday’s market action, saying stocks that saw losses — like Nvidia and Eli Lilly — remain…
How much people are willing to spend
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams…
Wegovy heart health approval won’t mean broad insurance coverage yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one…
The top 10 things to watch in the stock market Friday
Our top 10 things to watch Friday, March 15 1. Stocks opened lower Friday, following a losing day on Wall…
FDA approves NASH liver disease drug from Madrigal Pharmaceuticals
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images |…
Viking Therapeutics emerges as competitor
Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover…
Oprah is leaving WeightWatchers board, giving away all her stock
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. …
All the market-moving chatter from Wall Street Tuesday morning
(This is CNBC Pro’s live coverage of Tuesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to…
Here’s how I see the Fed’s rate-cut dilemma playing out
The following passage has been adapted from Jim Cramer’s opening monologue at Saturday’s annual meeting of the CNBC Investing Club.…
5 things next week that could determine if Wall Street win streak continues
Wall Street wrapped up another positive week, with the S & P 500 closing Friday above 5,000 for the first…
Novo Nordisk, Eli Lilly are tackling supply issues
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023.…
We’re not joining the sellers of Eli Lilly after its earnings results
Eli Lilly’s fourth-quarter results and 2024 sales guidance topped Wall Street expectations Tuesday, strengthening our investment case in the world’s…